Clinical Trial Update: Trial of Ixazomib for Kaposi Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of ixazomib for Kaposi sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• ixazomib (ixazomib)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Kaposi Sarcoma, Skin | Phase 2 | Status: RECRUITING